Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Quasispecies | 1 | 2020 | 108 | 0.77 | Why? |
| Keratitis, Herpetic | 2 | 2018 | 20 | 0.36 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.34 | Why? |
| Simplexvirus | 2 | 2017 | 124 | 0.33 | Why? |
| Herpesvirus 1, Human | 3 | 2018 | 286 | 0.31 | Why? |
| Herpesvirus 3, Human | 2 | 2018 | 228 | 0.30 | Why? |
| Roseolovirus Infections | 1 | 2005 | 131 | 0.27 | Why? |
| Paris | 4 | 2020 | 1287 | 0.27 | Why? |
| Herpesvirus 6, Human | 1 | 2005 | 162 | 0.26 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.25 | Why? |
| Drug Resistance, Viral | 3 | 2018 | 1083 | 0.24 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Frontal Lobe | 1 | 2020 | 191 | 0.19 | Why? |
| Membranes, Artificial | 1 | 2020 | 175 | 0.18 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.16 | Why? |
| Status Epilepticus | 1 | 2020 | 303 | 0.16 | Why? |
| Antiviral Agents | 6 | 2020 | 41703 | 0.15 | Why? |
| Heparitin Sulfate | 1 | 2018 | 285 | 0.15 | Why? |
| Lopinavir | 2 | 2020 | 4308 | 0.15 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.14 | Why? |
| Ritonavir | 2 | 2020 | 4212 | 0.14 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.14 | Why? |
| Regeneration | 1 | 2018 | 429 | 0.14 | Why? |
| Herpes Zoster | 1 | 2018 | 331 | 0.12 | Why? |
| Polymerase Chain Reaction | 2 | 2017 | 6740 | 0.12 | Why? |
| Cerebrovascular Disorders | 1 | 2020 | 1040 | 0.12 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Coinfection | 2 | 2020 | 6820 | 0.10 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.09 | Why? |
| Brain Diseases | 1 | 2020 | 1463 | 0.09 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.08 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.07 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Viral Proteins | 2 | 2020 | 7370 | 0.07 | Why? |
| Phylogeny | 2 | 2020 | 13341 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Infant | 3 | 2020 | 30274 | 0.07 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Renal Dialysis | 1 | 2020 | 4358 | 0.06 | Why? |
| Brain | 1 | 2020 | 5133 | 0.06 | Why? |
| Mutation | 2 | 2020 | 12376 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.06 | Why? |
| Mouth Mucosa | 1 | 2005 | 323 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.06 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.06 | Why? |
| Humans | 22 | 2021 | 930598 | 0.06 | Why? |
| Kidney Transplantation | 1 | 2021 | 5397 | 0.06 | Why? |
| DNA Primers | 1 | 2005 | 1170 | 0.05 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.05 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.05 | Why? |
| Thymidine Kinase | 1 | 2018 | 11 | 0.05 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.05 | Why? |
| Leukocytes | 1 | 2005 | 1046 | 0.04 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| DNA-Directed DNA Polymerase | 1 | 2018 | 47 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Intestinal Mucosa | 1 | 2005 | 1046 | 0.04 | Why? |
| Biomimetic Materials | 1 | 2018 | 70 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2021 | 632 | 0.04 | Why? |
| Acyclovir | 1 | 2017 | 154 | 0.04 | Why? |
| Herpesvirus 2, Human | 1 | 2017 | 137 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2018 | 8843 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.04 | Why? |
| Viral Plaque Assay | 1 | 2018 | 381 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.04 | Why? |
| Valine | 1 | 2017 | 359 | 0.04 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.04 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.03 | Why? |
| Genome | 1 | 2017 | 341 | 0.03 | Why? |
| Oseltamivir | 1 | 2018 | 583 | 0.03 | Why? |
| Herpes Simplex | 1 | 2017 | 272 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Tears | 1 | 2017 | 400 | 0.03 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.03 | Why? |
| General Practitioners | 1 | 2020 | 568 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Standard of Care | 1 | 2020 | 1297 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| France | 2 | 2020 | 12074 | 0.03 | Why? |
| Limit of Detection | 1 | 2020 | 2698 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Biological Evolution | 1 | 2017 | 641 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2017 | 1265 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2021 | 3567 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.02 | Why? |
| Saliva | 1 | 2005 | 4679 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Saudi Arabia | 1 | 2018 | 4423 | 0.02 | Why? |
| Recurrence | 1 | 2017 | 3675 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Heart Transplantation | 1 | 2018 | 1293 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Patient Isolation | 1 | 2018 | 3182 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2018 | 3629 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2017 | 3691 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.01 | Why? |
| Vero Cells | 1 | 2018 | 14117 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Travel | 1 | 2018 | 7220 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Boutolleau's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(167)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_